Comparison Overview
3D Biology | Molecular Devices
3D Biology | Molecular Devices
3860 N 1st St, San Jose, 95134, US
Last Update: 30/12/2025
Pioneering a new future of drug discovery rooted in 3D biology will empower researchers to personalize therapies, reduce a medicine’s time to market, and enhance quality of life for patients around the world. Molecular Devices has been a life sciences industry leader f...
Biocon
Hosur Road, Electronics City, Bangalore, Karnataka, IN, 560100
Last Update: 02/04/2026
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a...
Compliance Ranges Comparison
3D Biology | Molecular Devices
Biocon
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for 3D Biology | Molecular Devices in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Biocon in 2026.
Incident History - 3D Biology | Molecular Devices (X = Date, Y = Severity)
3D Biology | Molecular Devices cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Biocon (X = Date, Y = Severity)
Biocon cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
3D Biology | Molecular Devices
Biocon
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.